Sipoglitazar
Sipoglitazar is a selective PPARγ agonist investigated for the treatment of type 2 diabetes. It has been utilized in both in vitro assays and in vivo animal models to study insulin sensitization, glucose homeostasis, and metabolic syndrome pathways.
Product Specifications
CAS Number
342026-92-0
Field of Research
Metabolism Research, Molecular Biology
Smiles
C (CC (O) =O) C=1C (OCC) =NN (CC2=CC=C (OCC=3N=C (SC3) C4=CC=CC=C4) C=C2) C1
Molecular Formula
C25H25N3O4S
Molecular Weight
463.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6420041-01 0.1 mL
HDAC4, Phosphorylated (S632) (Histone Deacetylase 4, HD4, AHO3, BDMR, HDACA, HA6116, HDAC-4, HDAC-A) (Biotin)
Sign In for Pricing
View Details